Spire Healthcare Group PLC (FRA:S00)
€ 2.4 (0%) Market Cap: 1.01 Bil Enterprise Value: 2.49 Bil PE Ratio: 53.41 PB Ratio: 1.15 GF Score: 73/100

Full Year 2025 Spire Healthcare Group PLC Earnings Call Transcript

Mar 05, 2026 / 09:00AM GMT
Release Date Price: €2.08

Key Points

Positve
  • Spire Healthcare Group PLC (LSE:SPI) achieved a 4.5% growth in total revenue, with hospitals contributing a 4.3% increase.
  • The company successfully delivered GBP30 million in transformation savings, offsetting rising employment costs.
  • Spire Healthcare Group PLC (LSE:SPI) reported a 64.9% increase in adjusted free cash flow, demonstrating strong cash management.
  • The company maintained high care quality, with 98% of sites rated good or outstanding by regulators.
  • Spire Healthcare Group PLC (LSE:SPI) saw positive momentum in self-pay volumes, particularly in the second half of 2025.
Negative
  • The NHS business experienced slowing volumes in the second half of 2025 due to budgetary pressures, impacting overall growth.
  • Adjusted profit before tax decreased by 7.4% compared to the prior year, reflecting cost pressures.
  • The company faces significant uncertainty regarding NHS commissioning volumes for 2026, with potential revenue impacts.
  • Spire Healthcare Group PLC (LSE:SPI) experienced operational disruption during the summer due to changes in booking processes.
  • The company is subject to takeover panel rules, limiting the statements it can make about its strategic review and forecasts.
Justinian Ash
Spire Healthcare Group PLC - Chief Executive Officer, Executive Director

Thank you, and welcome, everybody, in the room and welcome, everybody, online. Very good to be here today. If you are joining for the first time, I'm Justin Ash, and I'm the Group Chief Executive of Spire Healthcare, and this is Harbant Samra, our CFO. So we're going to talk you through the results, and then we're going to leave lots of time for questions.

So let me start with a review of our strategic progress in 2025, the market context, how we're thinking about 2026 and how we're prioritizing in response. So the results we're sharing with you today demonstrate a resilient performance in the face of significant cost challenges and changes in the NHS commissioning environment towards the end of last year.

In response, we focused on consistent delivery of our strategic priorities. Our private focused multi-payor strategy, our transformation program that's delivering efficiencies through standardizing, centralizing and embedding digital and automation, our plan to grow in primary care, an area of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot